Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for …

D Macedo, AJM Chaves Filho, CNS de Sousa… - Journal of affective …, 2017 - Elsevier
Objectives The first drug repurposed for the treatment of depression was the tuberculostatic
iproniazid. At present, drugs belonging to new classes of antidepressants still have …

[HTML][HTML] Psychotropics and the microbiome: a chamber of secrets…

S Cussotto, G Clarke, TG Dinan, JF Cryan - Psychopharmacology, 2019 - Springer
The human gut contains trillions of symbiotic bacteria that play a key role in programming
different aspects of host physiology in health and disease. Psychotropic medications act on …

[HTML][HTML] Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder

Z Dong, X Shen, Y Hao, J Li, H Xu, L Yin… - Frontiers in …, 2022 - frontiersin.org
The therapeutic outcomes in major depressive disorder (MDD), one of the most common
and heterogeneous mental illnesses, are affected by factors that remain unclear and often …

[HTML][HTML] Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis

JR Kelly, G Clarke, A Harkin, SC Corr, S Galvin… - International Journal of …, 2023 - Elsevier
Moving towards a systems psychiatry paradigm embraces the inherent complex interactions
across all levels from micro to macro and necessitates an integrated approach to treatment …

Targeting the microbiota in pharmacology of psychiatric disorders

A Pascale, N Marchesi, S Govoni, A Barbieri - Pharmacological Research, 2020 - Elsevier
There is increasing interest in the role of the gut microbiota in health and disease. In
particular, gut microbiota influences the Central Nervous System (CNS) development and …

[HTML][HTML] The role of drug repurposing in the development of novel antimicrobial drugs: Non-antibiotic pharmacological agents as quorum sensing-inhibitors

M Gajdács, G Spengler - Antibiotics, 2019 - mdpi.com
Background: The emergence of multidrug-resistant organisms (MDROs) is a global public
health issue, severely hindering clinicians in administering appropriate antimicrobial …

Emerging role of Gut-microbiota-brain axis in depression and therapeutic implication

A Evrensel, KN Tarhan - Progress in Neuro-Psychopharmacology and …, 2021 - Elsevier
The human body can be considered a superorganism in which it's eukaryotic cells and
prokaryotic microorganisms coexist. Almost every organ system of the body lives a symbiotic …

[HTML][HTML] Gut microbiota in depression: a focus on ketamine

A Wilkowska, ŁP Szałach, WJ Cubała - Frontiers in Behavioral …, 2021 - frontiersin.org
According to the WHO, major depressive disorder is the leading cause of disability
worldwide, and it is a major contributor to the overall global burden of disease. The …

[HTML][HTML] The antimicrobial effects of ketamine combined with propofol: an in vitro study

Z Begec, A Yucel, Y Yakupogulları… - Revista Brasileira de …, 2013 - SciELO Brasil
Background and objectives: Ketamine and propofol are the general anesthetics that also
have antimicrobial and microbial growth-promoting effects, respectively. Although these …

Ketamine—a narrative review of its uses in medicine

BM Radvansky, S Puri, AN Sifonios… - American Journal of …, 2016 - journals.lww.com
One of the most fascinating drugs in the anesthesiologist's armament is ketamine, an N-
methyl-D-aspartate receptor antagonist with a myriad of uses. The drug is a dissociative …